Cargando…

Incorporation of podoplanin into HIV released from HEK-293T cells, but not PBMC, is required for efficient binding to the attachment factor CLEC-2

BACKGROUND: Platelets are associated with HIV in the blood of infected individuals and might modulate viral dissemination, particularly if the virus is directly transmitted into the bloodstream. The C-type lectin DC-SIGN and the novel HIV attachment factor CLEC-2 are expressed by platelets and facil...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaipan, Chawaree, Steffen, Imke, Tsegaye, Theodros Solomon, Bertram, Stephanie, Glowacka, Ilona, Kato, Yukinari, Schmökel, Jan, Münch, Jan, Simmons, Graham, Gerardy-Schahn, Rita, Pöhlmann, Stefan
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2885308/
https://www.ncbi.nlm.nih.gov/pubmed/20482880
http://dx.doi.org/10.1186/1742-4690-7-47
_version_ 1782182367519047680
author Chaipan, Chawaree
Steffen, Imke
Tsegaye, Theodros Solomon
Bertram, Stephanie
Glowacka, Ilona
Kato, Yukinari
Schmökel, Jan
Münch, Jan
Simmons, Graham
Gerardy-Schahn, Rita
Pöhlmann, Stefan
author_facet Chaipan, Chawaree
Steffen, Imke
Tsegaye, Theodros Solomon
Bertram, Stephanie
Glowacka, Ilona
Kato, Yukinari
Schmökel, Jan
Münch, Jan
Simmons, Graham
Gerardy-Schahn, Rita
Pöhlmann, Stefan
author_sort Chaipan, Chawaree
collection PubMed
description BACKGROUND: Platelets are associated with HIV in the blood of infected individuals and might modulate viral dissemination, particularly if the virus is directly transmitted into the bloodstream. The C-type lectin DC-SIGN and the novel HIV attachment factor CLEC-2 are expressed by platelets and facilitate HIV transmission from platelets to T-cells. Here, we studied the molecular mechanisms behind CLEC-2-mediated HIV-1 transmission. RESULTS: Binding studies with soluble proteins indicated that CLEC-2, in contrast to DC-SIGN, does not recognize the viral envelope protein, but a cellular factor expressed on kidney-derived 293T cells. Subsequent analyses revealed that the cellular mucin-like membranous glycoprotein podoplanin, a CLEC-2 ligand, was expressed on 293T cells and incorporated into virions released from these cells. Knock-down of podoplanin in 293T cells by shRNA showed that virion incorporation of podoplanin was required for efficient CLEC-2-dependent HIV-1 interactions with cell lines and platelets. Flow cytometry revealed no evidence for podoplanin expression on viable T-cells and peripheral blood mononuclear cells (PBMC). Podoplanin was also not detected on HIV-1 infected T-cells. However, apoptotic bystander cells in HIV-1 infected cultures reacted with anti-podoplanin antibodies, and similar results were obtained upon induction of apoptosis in a cell line and in PBMCs suggesting an unexpected link between apoptosis and podoplanin expression. Despite the absence of detectable podoplanin expression, HIV-1 produced in PBMC was transmitted to T-cells in a CLEC-2-dependent manner, indicating that T-cells might express an as yet unidentified CLEC-2 ligand. CONCLUSIONS: Virion incorporation of podoplanin mediates CLEC-2 interactions of HIV-1 derived from 293T cells, while incorporation of a different cellular factor seems to be responsible for CLEC-2-dependent capture of PBMC-derived viruses. Furthermore, evidence was obtained that podoplanin expression is connected to apoptosis, a finding that deserves further investigation.
format Text
id pubmed-2885308
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28853082010-06-15 Incorporation of podoplanin into HIV released from HEK-293T cells, but not PBMC, is required for efficient binding to the attachment factor CLEC-2 Chaipan, Chawaree Steffen, Imke Tsegaye, Theodros Solomon Bertram, Stephanie Glowacka, Ilona Kato, Yukinari Schmökel, Jan Münch, Jan Simmons, Graham Gerardy-Schahn, Rita Pöhlmann, Stefan Retrovirology Research BACKGROUND: Platelets are associated with HIV in the blood of infected individuals and might modulate viral dissemination, particularly if the virus is directly transmitted into the bloodstream. The C-type lectin DC-SIGN and the novel HIV attachment factor CLEC-2 are expressed by platelets and facilitate HIV transmission from platelets to T-cells. Here, we studied the molecular mechanisms behind CLEC-2-mediated HIV-1 transmission. RESULTS: Binding studies with soluble proteins indicated that CLEC-2, in contrast to DC-SIGN, does not recognize the viral envelope protein, but a cellular factor expressed on kidney-derived 293T cells. Subsequent analyses revealed that the cellular mucin-like membranous glycoprotein podoplanin, a CLEC-2 ligand, was expressed on 293T cells and incorporated into virions released from these cells. Knock-down of podoplanin in 293T cells by shRNA showed that virion incorporation of podoplanin was required for efficient CLEC-2-dependent HIV-1 interactions with cell lines and platelets. Flow cytometry revealed no evidence for podoplanin expression on viable T-cells and peripheral blood mononuclear cells (PBMC). Podoplanin was also not detected on HIV-1 infected T-cells. However, apoptotic bystander cells in HIV-1 infected cultures reacted with anti-podoplanin antibodies, and similar results were obtained upon induction of apoptosis in a cell line and in PBMCs suggesting an unexpected link between apoptosis and podoplanin expression. Despite the absence of detectable podoplanin expression, HIV-1 produced in PBMC was transmitted to T-cells in a CLEC-2-dependent manner, indicating that T-cells might express an as yet unidentified CLEC-2 ligand. CONCLUSIONS: Virion incorporation of podoplanin mediates CLEC-2 interactions of HIV-1 derived from 293T cells, while incorporation of a different cellular factor seems to be responsible for CLEC-2-dependent capture of PBMC-derived viruses. Furthermore, evidence was obtained that podoplanin expression is connected to apoptosis, a finding that deserves further investigation. BioMed Central 2010-05-19 /pmc/articles/PMC2885308/ /pubmed/20482880 http://dx.doi.org/10.1186/1742-4690-7-47 Text en Copyright ©2010 Chaipan et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Chaipan, Chawaree
Steffen, Imke
Tsegaye, Theodros Solomon
Bertram, Stephanie
Glowacka, Ilona
Kato, Yukinari
Schmökel, Jan
Münch, Jan
Simmons, Graham
Gerardy-Schahn, Rita
Pöhlmann, Stefan
Incorporation of podoplanin into HIV released from HEK-293T cells, but not PBMC, is required for efficient binding to the attachment factor CLEC-2
title Incorporation of podoplanin into HIV released from HEK-293T cells, but not PBMC, is required for efficient binding to the attachment factor CLEC-2
title_full Incorporation of podoplanin into HIV released from HEK-293T cells, but not PBMC, is required for efficient binding to the attachment factor CLEC-2
title_fullStr Incorporation of podoplanin into HIV released from HEK-293T cells, but not PBMC, is required for efficient binding to the attachment factor CLEC-2
title_full_unstemmed Incorporation of podoplanin into HIV released from HEK-293T cells, but not PBMC, is required for efficient binding to the attachment factor CLEC-2
title_short Incorporation of podoplanin into HIV released from HEK-293T cells, but not PBMC, is required for efficient binding to the attachment factor CLEC-2
title_sort incorporation of podoplanin into hiv released from hek-293t cells, but not pbmc, is required for efficient binding to the attachment factor clec-2
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2885308/
https://www.ncbi.nlm.nih.gov/pubmed/20482880
http://dx.doi.org/10.1186/1742-4690-7-47
work_keys_str_mv AT chaipanchawaree incorporationofpodoplaninintohivreleasedfromhek293tcellsbutnotpbmcisrequiredforefficientbindingtotheattachmentfactorclec2
AT steffenimke incorporationofpodoplaninintohivreleasedfromhek293tcellsbutnotpbmcisrequiredforefficientbindingtotheattachmentfactorclec2
AT tsegayetheodrossolomon incorporationofpodoplaninintohivreleasedfromhek293tcellsbutnotpbmcisrequiredforefficientbindingtotheattachmentfactorclec2
AT bertramstephanie incorporationofpodoplaninintohivreleasedfromhek293tcellsbutnotpbmcisrequiredforefficientbindingtotheattachmentfactorclec2
AT glowackailona incorporationofpodoplaninintohivreleasedfromhek293tcellsbutnotpbmcisrequiredforefficientbindingtotheattachmentfactorclec2
AT katoyukinari incorporationofpodoplaninintohivreleasedfromhek293tcellsbutnotpbmcisrequiredforefficientbindingtotheattachmentfactorclec2
AT schmokeljan incorporationofpodoplaninintohivreleasedfromhek293tcellsbutnotpbmcisrequiredforefficientbindingtotheattachmentfactorclec2
AT munchjan incorporationofpodoplaninintohivreleasedfromhek293tcellsbutnotpbmcisrequiredforefficientbindingtotheattachmentfactorclec2
AT simmonsgraham incorporationofpodoplaninintohivreleasedfromhek293tcellsbutnotpbmcisrequiredforefficientbindingtotheattachmentfactorclec2
AT gerardyschahnrita incorporationofpodoplaninintohivreleasedfromhek293tcellsbutnotpbmcisrequiredforefficientbindingtotheattachmentfactorclec2
AT pohlmannstefan incorporationofpodoplaninintohivreleasedfromhek293tcellsbutnotpbmcisrequiredforefficientbindingtotheattachmentfactorclec2